Hypertension and the development of New onset chronic kidney disease over a 10 year period: A retrospective cohort study in a primary care setting in Malaysia

BMC Nephrology

Volumn 13, Issue 1, 2012, Pages

  Chia, Yook Chin ^a,b   Ching, Siew Mooi ^c  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b CURTIN UNIVERSITY   (Australia)

^c UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Chronic kidney disease; Cohort, Malaysia; Estimated glomerular filtration rate; Hypertension; Primary care

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; URIC ACID;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; GROUPS BY AGE; HUMAN; HYPERTENSION; HYPERURICEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MEDICAL RECORD REVIEW; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; RISK ASSESSMENT; URBAN POPULATION; URIC ACID BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALAYSIA; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84871442598     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-13-173     Document Type: Article

References (46)

1. Current Status of Chronic Kidney Disease Care in Southeast Asia. Jha V, Semin Nephrol 2009 29 5 487 496 10.1016/j.semnephrol.2009.06.005 19751894
2. Chronic kidney disease: the global challenge. El Nahas AM, Bello AK, Lancet 2005 365 9456 331 340 15664230 (Pubitemid 40139112)
3. Hypertension, hypertension control, and chronic kidney disease in a Malay population in Singapore. Sabanayagam C, Shankar A, Lim SC, Tai ES, Wong TY, Asia-Pac J Public He 2011 23 6 936 945 10.1177/1010539510361637
4. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J, J Am Soc Nephrol 2003 14 11 2934 2941 10.1097/01.ASN.0000095249.99803.85 14569104 (Pubitemid 37305656)
5. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. Ann Intern Med 2003 139 2 137 12859163
6. Hypertension and kidney disease: a deadly connection. Barri YM, Curr Cardiol Rep 2006 8 411 417 10.1007/s11886-006-0098-7 17059792 (Pubitemid 44742136)
7. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, et al. Circulation 2003 108 17 2154 2169 10.1161/01.CIR.0000095676.90936.80 14581387 (Pubitemid 37337595)
8. Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). Lenfant C, Chobanian AV, Jones DW, Roccella EJ, Circulation 2003 107 24 2993 2994 10.1161/01.CIR.0000080481.62058.03
9. The burden of kidney disease: improving global outcomes. Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A, Levin N, Locatelli F, MacLeod A, Vanholder R, Walker R, et al. Kidney Int 2004 66 4 1310 1314 10.1111/j.1523-1755.2004.00894.x 15458424 (Pubitemid 39302630)
10. Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter. Levin A, Djurdjev O, Barrett B, Burgess E, Carlisle E, Ethier J, Jindal K, Mendelssohn D, Tobe S, Singer J, et al. Am J Kidney Dis 2001 38 6 1398 1407 10.1053/ajkd.2001.29275 11728982 (Pubitemid 34193134)
11. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C, N Engl J Med 2004 351 13 1296 1305 10.1056/NEJMoa041031 15385656 (Pubitemid 39268908)
12. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT, Lancet 2010 375 9731 2073 2081 20483451
13. Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension. Hanratty R, Chonchol M, Miriam Dickinson L, Beaty BL, Estacio RO, Mackenzie TD, Hurley LP, Linas SL, Steiner JF, Havranek EP, Nephrol Dial Transplant 2010 25 3 801 807 10.1093/ndt/gfp534 19889870
14. Longitudinal studies on the rate of decline in renal function with age. Lindeman RD, Tobin J, Shock NW, J Am Geriatr Soc 1985 33 4 278 3989190
15. Assessing Kidney Function-Measured and Estimated Glomerular Filtration Rate. Stevens Lesley A, Coresh J, Greene T, Levey Andrew S, N Engl J Med 2006 354 23 2473 2483 10.1056/NEJMra054415 16760447 (Pubitemid 43855050)
16. Hypertension-associated kidney disease: perhaps no more. Freedman BI, Sedor JR, J Am Soc Nephrol 2008 19 11 2047 2051 10.1681/ASN.2008060621 18923054
17. Blood pressure and end-stage renal disease in men. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J, N Engl J Med 1996 334 1 13 18 10.1056/NEJM199601043340103 7494564 (Pubitemid 26012498)
18. Importance of blood pressure control in chronic kidney disease. Ravera M, Re M, Deferrari L, Vettoretti S, Deferrari G, J Am Soc Nephrol 2006 17 4 suppl 2 98 S103 16565257
19. Standards of medical care in diabetes. Fonseca V, Clark NG, Diabetes Care 2006 29 2 476 477 16482699
20. Concordance of Serum Creatinine to Estimated Glomerular Filtration Rate in Determining Early Chronic Kidney Disease in Malaysia. Chia Yook C, Ching Siew M, Life Science Journal 2012 9 3 453 457
21. Performance of the Modification of Diet in Renal Disease and Cockcroft-Gault Equations in the Estimation of GFR in Health and in Chronic Kidney Disease. Poggio ED, Wang X, Greene T, Van Lente F, Hall PM, J Am Soc Nephrol 2005 16 2 459 466 10.1681/ASN.2004060447 15615823 (Pubitemid 41725142)
22. Serum Creatinine Is an Inadequate Screening Test for Renal Failure in Elderly Patients. Swedko PJ, Clark HD, Paramsothy K, Akbari A, Arch Intern Med 2003 163 3 356 360 10.1001/archinte.163.3.356 12578517 (Pubitemid 36183865)
23. Prediction of creatinine clearance from serum creatinine [abstract]. Cockcroft DW, Gault MH, Nephron 1976 16 1 31 10.1159/000180580 1244564
24. Chronic kidney disease in hypertension under specialist care: the I-DEMAND study. Leoncini G, Viazzi F, Rosei EA, Ambrosioni E, Costa FV, Leonetti G, Pessina AC, Trimarco B, Volpe M, Deferrari G, et al. J Hypertens 2010 28 1 156 162 10.1097/HJH.0b013e328332038c 19915481
25. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Keane WF, Brenner BM, de Zeeuw D, Grunfeld JP, McGill J, Mitch WE, Ribeiro AB, Shahinfar S, Simpson RL, Snapinn SM, et al. Kidney Int 2003 63 4 1499 1507 10.1046/j.1523-1755.2003.00885.x 12631367 (Pubitemid 36350016)
26. The role of angiotensin II receptor blockers in preventing the progression of renal disease in patients with type 2 diabetes [abstract]. Lewis EJ, Am J Hypertens 2002 15 123 s128 10.1016/S0895-7061(02)03007-8
27. Chronic kidney disease in patients with diabetes mellitus type 2 or hypertension in general practice. Van der Meer V, Wielders HP, Grootendorst DC, de Kanter JS, Sijpkens YW, Assendelft WJ, Gussekloo J, Dekker FW, Groeneveld Y, Br J Gen Pract 2010 60 581 884 890 10.3399/bjgp10X544041 21144198
28. Hypertension and angiogenesis in the aging kidney: A review. Duarte D, Santos Araujo C, Leite-Moreira AF, Arch Gerontol Geriatr 2011 52 3 93 e102 10.1016/j.archger.2010.11.032 21176977
29. Renal tubulointerstitial expansion is associated with endothelial dysfunction and inflammation in type 1 diabetes. Bangstad HJ, Seljeflot I, Berg T, Hanssen K, Scand J Clin Lab Invest 2009 69 1 138 144 10.1080/ 00365510802444080 18846477
30. Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury. Phillips AO, Steadman R, Histol Histopathol 2002 17 1 247 252 11813875 (Pubitemid 34116428)
31. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Mogensen CE, Br Med J (Clin Res Ed) 1982 285 6343 685 688 10.1136/bmj.285.6343.685 (Pubitemid 12051454)
32. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Parving HH, Andersen AR, Smidt UM, Svendsen PA, Lancet 1983 1 8335 1175 1179 6133986 (Pubitemid 13092704)
33. Monitoring glomerular function in diabetic nephropathy. A prospective study. Viberti GC, Bilous RW, Mackintosh D, Keen H, Am J Med 1983 74 2 256 264 10.1016/0002-9343(83)90624-1 6401924 (Pubitemid 13192182)
34. Long-term effects of antihypertensive agents on proteinuria and renal function. Maki DD, Ma JZ, Louis TA, Kasiske BL, Arch Intern Med 1995 155 10 1073 1080 10.1001/archinte.1995.00430100105012 7748051
35. Diabetic Renal Disease: The Quest for Normotension-and Beyond. Mogensen CE, Diabetic Med 1995 12 9 756 769 10.1111/j.1464-5491.1995.tb02077.x 8542735
36. Relationship of uric acid with progression of kidney disease. Chonchol M, Shlipak MG, Katz R, Sarnak MJ, Newman AB, Siscovick DS, Kestenbaum B, Carney JK, Fried LF, Am J Kidney Dis 2007 50 2 239 247 10.1053/j.ajkd.2007.05.013 17660025 (Pubitemid 47095076)
37. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study. Sturm G, Kollerits B, Neyer U, Ritz E, Kronenberg F, Exp Gerontol 2008 43 4 347 352 10.1016/j.exger.2008.01.006 18294794
38. Uric acid and cardiovascular risk. Feig DI, Kang DH, Johnson RJ, N Engl J Med 2008 359 17 1811 1821 10.1056/NEJMra0800885 18946066
39. Uric Acid and Chronic Kidney Disease: New Understanding of an Old Problem. Kang D-H, Chen W, Semin Nephrol 2011 31 5 447 452 10.1016/j.semnephrol. 2011.08.009 22000652
40. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Goicoechea M, de Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, Rincon A, Arroyo D, Luno J, Clin J Am Soc Nephrol 2010 5 8 1388 1393 10.2215/CJN.01580210 20538833
41. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Siu YP, Leung KT, Tong MKH, Kwan TH, Am J Kidney Dis 2006 47 1 51 59 10.1053/j.ajkd.2005.10.006 16377385 (Pubitemid 41828266)
42. Telmisartan, ramipril, or both in patients at high risk for vascular events. Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C, N Engl J Med 2008 358 15 1547 1559 18378520 (Pubitemid 351522739)
43. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, Narita M, Koyama A, Kidney Int 2007 71 2 159 166 10.1038/sj.ki.5002017 17136030 (Pubitemid 46094690)
44. Proteinuria and the risk of developing end-stage renal disease. Iseki K, Ikemiya Y, Iseki C, Takishita S, Kidney Int 2003 63 4 1468 1474 10.1046/j.1523-1755.2003.00868.x 12631363 (Pubitemid 36350012)
45. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis. Balamuthusamy S, Srinivasan L, Verma M, Adigopula S, Jalandhara N, Hathiwala S, Smith E, Am Heart J 2008 155 5 791 805 10.1016/j.ahj.2008.01.031 18440325 (Pubitemid 351601744)
46. Evaluation of the modification of diet in renal disease study equation in a large diverse population. Stevens LA, Coresh J, Feldman HI, Greene T, Lash JP, Nelson RG, Rahman M, Deysher AE, Zhang YL, Schmid CH, et al. J Am Soc Nephrol 2007 18 10 2749 2757 10.1681/ASN.2007020199 17855641 (Pubitemid 47531202)